Sarilumab in patients admitted to hospital with severe or critical COVID-19: a randomised, double-blind, placebo-controlled, phase 3 trial - François-Xavier Lescure; Hitoshi Honda; Robert A Fowler; Jennifer Sloane Lazar; Genming Shi; Peter Wung; Naimish Patel; Owen Hagino; Ignacio J Bazzalo; Marcelo M Casas; Sebastián A Nuñez; Yael Pere; et al. (The Lancet Respiratory Medicine, 2021)